Evaluation of the Safety, Tolerability and Pharmacokinetics (PK) of GSK3732394 First-Time-in-Human (FTIH) Study
Clinical trial NCT03984812 · TERMINATED
Trial details
- NCT number
- NCT03984812
- Sponsor
- ViiV Healthcare
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-17
- Primary completion
- 2020-03-23
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.